Showing results (921-930 of 2,915) with videos related to
Sort By:
Pageof 292
Cancer Gene Therapy|July 1, 1997
Increase of cytotoxic sensitivity of primary human melanoma cells transfected with the interleukin-7 gene to autologous and allogeneic immunologic effector cellsS Finke, B Trojaneck, P Möller, et al.Cancer Gene Therapy|July 1, 1997
Selective augmentation of radiation effects by 5-fluorocytosine on murine B16(F10) melanoma cells transfected with cytosine deaminase geneJ Szary, E Missol, R Tarnawski, et al.Cancer Gene Therapy|December 31, 1997
Vaccination for experimental gliomas using GM-CSF-transduced glioma cellsU Herrlinger, C M Kramm, K M Johnston, et al.Cancer Gene Therapy|December 31, 1997
In vitro and in vivo characteristics of human squamous cell carcinoma of the head and neck cells engineered to secrete interleukin-2S Nagashima, T E Reichert, Y Kashii, et al.Cancer Gene Therapy|December 31, 1997
Cervical carcinoma cells transfected with the CD80 gene elicit a primary cytotoxic T lymphocyte response specific for HPV 16 E7 antigensA M Kaufmann, L Gissmann, C Schreckenberger, et al.Cancer Gene Therapy|February 26, 1998
Characterization and tumorigenicity of human neuroblastoma cells transfected with the IL-2 geneM V Corrias, S Basso, R Meazza, et al.Cancer Gene Therapy|February 26, 1998
Selection of a high activity c-erbB-2 ribozyme using a fusion gene of c-erbB-2 and the enhanced green fluorescent proteinK Wiechen, C Zimmer, M DietelCancer Gene Therapy|November 8, 2003
A novel antisense inhibitor of MMP-9 attenuates angiogenesis, human prostate cancer cell invasion and tumorigenicityCarla A London, Harmanjatinder S Sekhon, Vikram Arora, et al.Cancer Gene Therapy|November 8, 2003
Induction of CD8 T-cell-Ifn-gamma response and positive clinical outcome after immunization with gene-modified allogeneic tumor cells in advanced non-small-cell lung carcinomaLuis E Raez, Peter A Cassileth, James J Schlesselman, et al.Cancer Gene Therapy|May 28, 2003
Gene therapy for hepatocellular carcinoma using non-viral vectors composed of bis guanidinium-tren-cholesterol and plasmids encoding the tissue inhibitors of metalloproteinases TIMP-2 and TIMP-3Phuong-Lan Tran, Jean-Pierre Vigneron, David Pericat, et al.Pageof 292